Literature DB >> 19772382

Comparative evaluation of the powder and compression properties of various grades and brands of microcrystalline cellulose by multivariate methods.

Rahul V Haware1, Annette Bauer-Brandl, Ingunn Tho.   

Abstract

The present work challenges a newly developed approach to tablet formulation development by using chemically identical materials (grades and brands of microcrystalline cellulose). Tablet properties with respect to process and formulation parameters (e.g. compression speed, added lubricant and Emcompress fractions) were evaluated by 2(3)-factorial designs. Tablets of constant true volume were prepared on a compaction simulator at constant pressure (approx. 100 MPa). The highly repeatable and accurate force-displacement data obtained was evaluated by simple 'in-die' Heckel method and work descriptors. Relationships and interactions between formulation, process and tablet parameters were identified and quantified by multivariate analysis techniques; principal component analysis (PCA) and partial least square regressions (PLS). The method proved to be able to distinguish between different grades of MCC and even between two different brands of the same grade (Avicel PH 101 and Vivapur 101). One example of interaction was studied in more detail by mixed level design: The interaction effect of lubricant and Emcompress on elastic recovery of Avicel PH 102 was demonstrated to be complex and non-linear using the development tool under investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19772382     DOI: 10.3109/10837450903262041

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Tableting properties of microcrystalline cellulose obtained from wheat straw measured with a single punch bench top tablet press.

Authors:  Jovana Krivokapić; Jasna Ivanović; Jelena Djuriš; Djordje Medarević; Zorica Potpara; Zoran Maksimović; Svetlana Ibrić
Journal:  Saudi Pharm J       Date:  2020-05-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.